pd 173074 has been researched along with Bile Duct Cancer in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cholangiocarcinoma is an intractable cancer, with limited therapeutic options, in which the molecular mechanisms underlying tumor development remain poorly understood." | 1.40 | Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. ( Arai, Y; Furuta, K; Hama, N; Hosoda, F; Kosuge, T; Nakamura, H; Ojima, H; Okusaka, T; Shibata, T; Shimada, K; Shirota, T; Totoki, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, Y | 1 |
| Totoki, Y | 1 |
| Hosoda, F | 1 |
| Shirota, T | 1 |
| Hama, N | 1 |
| Nakamura, H | 1 |
| Ojima, H | 1 |
| Furuta, K | 1 |
| Shimada, K | 1 |
| Okusaka, T | 1 |
| Kosuge, T | 1 |
| Shibata, T | 1 |
1 other study available for pd 173074 and Bile Duct Cancer
| Article | Year |
|---|---|
Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.
Topics: Adenosylhomocysteinase; Aged; Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hep | 2014 |